Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Infectious Disease
•
General Infectious Disease
Do you give lifelong anti fungal therapy or a set time period of anti fungal therapy to patients who have vertebral hardware infection with some residual hardware that cannot be removed?
Related Questions
Do you find HZV titers useful in diagnosing shingles sine herpete?
Do you recommend antibiotic prophylaxis for an ESKD patient with a tunneled dialysis catheter who is planned for a dental procedure?
In patients with possible Bartonella henselae infection and elevated IgG titer, what is the best way to confirm the diagnosis: tissue biopsy with Warthin-Starry staining, tissue sent for Bartonella henselae PCR, or tissue sent for culture?
How long do you continue antibiotics after cholecystostomy tube placement for acute cholecystitis?
Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?
Do you recommend routine ophthalmologic exam for all patients with hypervirulent Klebsiella pneumoniae bacteremia?
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
Do you routinely treat chronic sacral osteomyelitis when there is no plan for debridement or flap?
Would you consider antifungal prophylaxis for immunocompromised patients with COVID-19 requiring mechanical ventilation, considering the high risk of invasive pulmonary aspergillosis in patients with severe COVID-19?